Buhler Industries Inc. is pleased to announce that it has executed a definitive Amalgamation Agreement (the "Amalgamation Agreement") with ASKO Sinai ve Teknoloji Üretim Sanayi Ticaret Anonim Şirketi ("ASKO") and a wholly-owned subsidiary of ASKO ("Newco") pursuant to which the Company would be taken private by way of an amalgamation (the "Amalgamation"). ASKO owns 24,184,586 Class A common shares ("Common Shares") representing approximately 96.7% of the Company's 25,000,000 issued and outstanding Common Shares. Prior to the Amalgamation, ASKO will transfer all of its Common Shares to Newco in exchange for common shares of Newco by way of a share exchange agreement.
Under the Amalgamation Agreement, the Company and Newco would amalgamate and continue as one company ("Amalco"). Pursuant to the Amalgamation: (i) each Common Share of the Company owned by public shareholders other than Newco (the "Minority Shareholders") would be converted into one redeemable preferred share of Amalco (an "Amalco Redeemable Preferred Share") and each Amalco Redeemable Preferred Share would then be redeemed by Amalco for CDN$7.30 (the "Redemption Amount") in cash immediately following completion of the Amalgamation; (ii) the Common Shares held by Newco would be cancelled without payment of capital; and (iii) ASKO would receive one common share in the capital of Amalco for each common share it holds in the capital of Newco. Upon completion of the Amalgamation and the subsequent redemption by Amalco of the outstanding Amalco Redeemable Preferred Shares, Amalco would continue to operate as a private company, wholly owned by ASKO under the Canada Business Corporations Act (the "CBCA").
The board of directors of the Company (the "Board") formed a special committee (the "Special Committee") comprised of Mr. Ossama AbouZeid as the sole independent director of the Company, to evaluate the Amalgamation and make recommendations to the Board. The Special Committee has engaged Burnet, Duckworth & Palmer LLP as its legal advisor.
The Special Committee retained PricewaterhouseCoopers LLP ("PwC") as its financial advisor to advise with respect to the financial fairness of the Amalgamation. PwC has provided a fairness opinion (the "Fairness Opinion") to the Special Committee to the effect that, as at February 11, 2025, and subject to the assumptions, limitations and qualifications contained therein, the consideration offered pursuant the Amalgamation is fair, from a financial point of view, to the Minority Shareholders. The Special Committee also retained PwC to prepare and deliver a formal valuation (the "Formal Valuation") of the Common Shares under the supervision of the Special Committee. The Redemption Amount is within the range of the fair market value per Common Share that PwC determined in the Formal Valuation, as at February 11, 2025, subject to the assumptions, qualifications and limitations provided therein.v
Based on PwC's conclusions, among other matters considered, the Special Committee determined that the Amalgamation is in the best interests of the Company and is fair, from a financial point of view, to the Minority Shareholders. In light of the conclusions of the Special Committee and PwC, the Board (with the nominees of ASKO on the Board recusing themselves) approved the Amalgamation and recommends that shareholders vote in favour of the Amalgamation.
The Company has called a special meeting (the "Meeting") of shareholders of the Company to approve the Amalgamation (the "Amalgamation Resolution"). The Meeting will be held on or about March 28, 2025. Shareholders of record as of February 27, 2025, will be eligible to vote and an information circular will be mailed to such shareholders in the coming weeks. Copies of the Fairness Opinion, the Formal Valuation and a description of the various factors considered by the Special Committee and the Board in their determination to approve the Amalgamation, as well as other relevant background information, will be included in the information circular. The Minority Shareholders are entitled to dissent rights in respect of the Amalgamation Resolution pursuant to section 190 of the CBCA.
The Amalgamation, if consummated, will constitute a "business combination" for the purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). As Newco will hold over 90% of the issued and outstanding Common Shares and the remaining shareholders would be given appraisal rights prescribed by corporate law, the Amalgamation will, pursuant to Section 4.6(1)(a) of MI 61-101, be exempt from the minority shareholder approval requirements of MI 61-101.
Following the completion of the Amalgamation, the Common Shares will be de-listed from the Toronto Stock Exchange and the Company will apply to cease to be a reporting issuer under applicable Canadian securities laws. Copies of the Amalgamation Agreement and certain related documents will be available on SEDAR+ at sedarplus.ca.
The Amalgamation is subject to a number of conditions including the approval of the Amalgamation Resolution by at least two-thirds of the votes cast by holders of Common Shares at the Meeting (including votes cast by Newco). Assuming the satisfaction of all conditions, the Amalgamation is expected to close as soon as practicable following the Meeting. There is no assurance that the Amalgamation will be completed on the terms as proposed or at all.